https://www.selleckchem.com/products/rcm-1.html
Patients with cancer might be at an increased risk of infection with COVID-19 and a more severe disease course. However, different tumor types have differing susceptibility to the infection and COVID-19 phenotypes. Thus, the risk and prevalence of COVID-19 is not uniform across the different tumor types. Here, we performed a meta-analysis to estimate the risk and prevalence of COVID-19 infection in colorectal cancer (CRC) patients. A comprehensive literature search was performed up to July 25, 2020, thorough PubMed, Web of Science, Scopus
Like
Comment
Share
